NKTR vs NXPI · rev $21.0M vs P/E 29, rev $12.27B
Nektar Therapeutics (NKTR) versus NXP Semiconductors NV (NXPI) — a side-by-side from cached financials, not a winner call.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
NKTR currently screens at market cap $307.2M. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Not investment advice. Open the NKTR and NXPI stock pages for the full models.
Not investment advice.